IC
TEVA icon

IEQ Capital’s Teva Pharmaceuticals TEVA Stock Holding History

IEQ Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.28M Buy
42,533
+707
+2% +$22.7K 0.01% 936
2025
Q4 		$1.31M Buy
41,826
+6,201
+17% +$153K ﹤0.01% 934
2025
Q3 		$720K Buy
+35,625
New +$626K ﹤0.01% 1141
2023
Q3 		– Sell
-100,404
Closed -$756K – 965
2023
Q2 		$756K Buy
100,404
+404
+0.4% +$3.28K 0.02% 456
2023
Q1 		$885K Buy
+100,000
New +$989K 0.02% 418

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IEQ Capital's TEVA Position: Q1 2026 in Review

IEQ Capital increased its Teva Pharmaceuticals (TEVA) stake by 1.7% in Q1 2026, buying an estimated $22.7K and bringing the position to 42,533 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #936.

IEQ Capital first reported a position in TEVA in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.31M in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • IEQ Capital held 42,533 shares of Teva Pharmaceuticals worth $1.28M as of Q1 2026.
  • IEQ Capital bought 707 Teva Pharmaceuticals shares in Q1 2026, an estimated $22.7K.
  • Teva Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q1 2026, its #936 holding.
  • IEQ Capital first reported a position in Teva Pharmaceuticals in Q1 2023 and has held it in 5 quarters since.
  • IEQ Capital's Teva Pharmaceuticals position peaked at $1.31M in Q4 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.